Dr. John is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 16th St nw
Miami, FL 33125Phone+1 305-575-7000
Summary
- Dr. Binu John is a gastroenterologist and hepatologist in Miami, FL. He specializes in hepatology & liver transplantation, is an Affiliate Associate Professor, University of Miami Miller School of Medicine and Chief of Hepatology at the Bruce W Carters VA Medical Center. He is experienced in hepatology, transplant hepatology, portal hypertension, and hepatocellular carcinoma.
Education & Training
- Cleveland Clinic FoundationFellowship, Gastroenterology, 2007 - 2010
- Cleveland Clinic FoundationResidency, Internal Medicine, 2005 - 2007
- Christian Medical College VelloreClass of 1998
Certifications & Licensure
- FL State Medical License 2013 - 2025
- VA State Medical License 2016 - 2022
- OH State Medical License 2005 - 2018
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 386 citationsFecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialJasmohan S. Bajaj, Zain Kassam, Andrew Fagan, Edith Gavis, Eric J. Liu
Hepatology. 2017-12-01 - 133 citationsFontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DCCurt J. Daniels, Elisa A. Bradley, Mike Landzberg, Jamil Aboulhosn, Robert H. Beekman
Journal of the American College of Cardiology. 2017-12-26 - 47 citationsPostvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.Binu V John, Yangyang Deng, Kaley B Schwartz, Tamar H Taddei, David E Kaplan
Hepatology. 2022-07-01
Press Mentions
- Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%November 7th, 2022
- Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis PatientsOctober 26th, 2022
- Miller School Faculty Front and Center at DDW ’22June 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: